Cargando…

Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer

Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Pagliarulo, Fabio, Cheng, Phil F., Brugger, Laurin, van Dijk, Nick, van den Heijden, Michiel, Levesque, Mitchell P., Silina, Karina, van den Broek, Maries
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821902/
https://www.ncbi.nlm.nih.gov/pubmed/35145509
http://dx.doi.org/10.3389/fimmu.2021.793992
_version_ 1784646496153501696
author Pagliarulo, Fabio
Cheng, Phil F.
Brugger, Laurin
van Dijk, Nick
van den Heijden, Michiel
Levesque, Mitchell P.
Silina, Karina
van den Broek, Maries
author_facet Pagliarulo, Fabio
Cheng, Phil F.
Brugger, Laurin
van Dijk, Nick
van den Heijden, Michiel
Levesque, Mitchell P.
Silina, Karina
van den Broek, Maries
author_sort Pagliarulo, Fabio
collection PubMed
description Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Genome Atlas, as well as the IMvigor210 dataset to study factors associated with TLS development and function in the tumor microenvironment (TME) of MIBC. We also analyzed tumor immune composition including TLS in an independent, retrospective MIBC cohort. We found that the combination of TLS density and tumor mutational burden provides a novel independent prognostic biomarker in MIBC. Gene expression profiles obtained from intratumoral regions that rarely contain TLS in MIBC showed poor correlation with the prognostic TLS density measured in tumor periphery. Tumors with high TLS density showed increased gene signatures as well as infiltration of activated lymphocytes. Intratumoral B-cell and CD8(+) T-cell co-infiltration was frequent in TLS-high samples, and such regions harbored the highest proportion of PD-1(+)TCF1(+) progenitor-like T cells, naïve T cells, and activated B cells when compared to regions predominantly infiltrated by either B cells or CD8(+) T cells alone. We found four TLS maturation subtypes; however, differences in TLS composition appeared to be dictated by the TME and not by the TLS maturation status. Finally, we identified one downregulated and three upregulated non-immune cell-related genes in TME with high TLS density, which may represent candidates for tumor-intrinsic regulation of lymphoid neogenesis. Our study provides novel insights into TLS-associated gene expression and immune contexture of MIBC and indicates towards the relevance of B-cell and CD8(+) T-cell interactions in anti-tumor immunity within and outside TLS.
format Online
Article
Text
id pubmed-8821902
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88219022022-02-09 Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer Pagliarulo, Fabio Cheng, Phil F. Brugger, Laurin van Dijk, Nick van den Heijden, Michiel Levesque, Mitchell P. Silina, Karina van den Broek, Maries Front Immunol Immunology Lymphoid neogenesis gives rise to tertiary lymphoid structures (TLS) in the periphery of multiple cancer types including muscle invasive bladder cancer (MIBC) where it has positive prognostic and predictive associations. Here, we explored molecular, clinical, and histological data of The Cancer Genome Atlas, as well as the IMvigor210 dataset to study factors associated with TLS development and function in the tumor microenvironment (TME) of MIBC. We also analyzed tumor immune composition including TLS in an independent, retrospective MIBC cohort. We found that the combination of TLS density and tumor mutational burden provides a novel independent prognostic biomarker in MIBC. Gene expression profiles obtained from intratumoral regions that rarely contain TLS in MIBC showed poor correlation with the prognostic TLS density measured in tumor periphery. Tumors with high TLS density showed increased gene signatures as well as infiltration of activated lymphocytes. Intratumoral B-cell and CD8(+) T-cell co-infiltration was frequent in TLS-high samples, and such regions harbored the highest proportion of PD-1(+)TCF1(+) progenitor-like T cells, naïve T cells, and activated B cells when compared to regions predominantly infiltrated by either B cells or CD8(+) T cells alone. We found four TLS maturation subtypes; however, differences in TLS composition appeared to be dictated by the TME and not by the TLS maturation status. Finally, we identified one downregulated and three upregulated non-immune cell-related genes in TME with high TLS density, which may represent candidates for tumor-intrinsic regulation of lymphoid neogenesis. Our study provides novel insights into TLS-associated gene expression and immune contexture of MIBC and indicates towards the relevance of B-cell and CD8(+) T-cell interactions in anti-tumor immunity within and outside TLS. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8821902/ /pubmed/35145509 http://dx.doi.org/10.3389/fimmu.2021.793992 Text en Copyright © 2022 Pagliarulo, Cheng, Brugger, van Dijk, van den Heijden, Levesque, Silina and van den Broek https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Pagliarulo, Fabio
Cheng, Phil F.
Brugger, Laurin
van Dijk, Nick
van den Heijden, Michiel
Levesque, Mitchell P.
Silina, Karina
van den Broek, Maries
Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title_full Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title_fullStr Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title_full_unstemmed Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title_short Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer
title_sort molecular, immunological, and clinical features associated with lymphoid neogenesis in muscle invasive bladder cancer
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821902/
https://www.ncbi.nlm.nih.gov/pubmed/35145509
http://dx.doi.org/10.3389/fimmu.2021.793992
work_keys_str_mv AT pagliarulofabio molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT chengphilf molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT bruggerlaurin molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT vandijknick molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT vandenheijdenmichiel molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT levesquemitchellp molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT silinakarina molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer
AT vandenbroekmaries molecularimmunologicalandclinicalfeaturesassociatedwithlymphoidneogenesisinmuscleinvasivebladdercancer